Abstract
Both parathyroid hormone (PTH) and fibroblast growth factor 23 (FGF23) are phosphaturic hormones. These hormones should increase in response to phosphate excess. However, they also regulate serum calcium; PTH increases serum calcium concentration and FGF23 suppresses renal production of calcitriol, favoring hypocalcemia. We report the case of an 83-year-old woman with hyperphosphatemia and hypocalcemia resulting from phosphate-containing enemas. PTH and calcitriol increased in response to hypocalcemia, and FGF23 increased in response to hyperphosphatemia. Unexpectedly, peak FGF23 did not coincide with peak serum phosphate. Rather, peak FG23 was observed only after severe hypocalcemia was partially corrected with exogenous calcium administration, even though serum phosphate had been already decreasing for 32 h. Correction of severe hypocalcemia was thus associated with peak FGF23 values and with a precipitous decrease in PTH. Peak FGF23 was followed by an accelerated decrease in serum phosphate and significant phosphaturia. This clinical report is consistent with experimental data in rats showing a blunted FGF23 response to high phosphate in the presence of severe hypocalcemia. Thus, complementary experimental and clinical data suggest that partial correction of severe hypocalcemia is required for optimal FGF23-mediated phosphaturia, which takes place despite correction of PTH levels. We believe this the first human report suggesting blunting of the FGF23 response to high phosphate by severe hypocalcemia.
Similar content being viewed by others
References
Gonzalez-Parra E, Tuñón J, Egido J, Ortiz A (2012) Phosphate: a stealthier killer than previously thought? Cardiovasc Pathol (Epub ahead of print)
Krajisnik T, Bjorklund P, Marsell R, Ljunggren O, Akerström G, Jonsson KB, Westin G, Larsson TE (2007) Fibroblast growth factor-23 regulates parathyroid hormone and 1 alpha-hydroxylase expression in cultured bovine parathyroid cells. J Endocrinol 195:125–131
Gonzalez-Parra E, Gonzalez-Casaus ML, Galán A, Martinez-Calero A, Navas V, Rodriguez M, Ortiz A (2011) Lanthanum carbonate reduces FGF23 in chronic kidney disease Stage 3 patients. Nephrol Dial Transplant 26:2567–2571
Berndt T, Thomas LF, Craig TA, Sommer S, Li X, Bergstralh EJ, Kumar R (2007) Evidence for a signaling axis by which intestinal phosphate rapidly modulates renal phosphate reabsorption. Proc Natl Acad Sci USA 104:11085–11090
Hsu HJ, Wu MS (2008) Extreme hyperphosphatemia and hypocalcemic coma associated with phosphate enema. Intern Med 47:643–646
Reedy JC, Zwiren GT (1983) Enema-induced hypocalcemia and hyperphosphatemia leading to cardiac arrest during induction of anesthesia in an outpatient surgery center. Anesthesiology 59:578–579
Ori Y, Rozen-Zvi B, Chagnac A, Herman M, Zingerman B, Atar E, Gafter U, Korzets A (2012) Fatalities and severe metabolic disorders associated with the use of sodium phosphate enemas: a single center’s experience. Arch Intern Med 172:263–265
Desmeules S, Bergeron MJ, Isering P (2003) Acute phosphate nephropathy and renal failure. N Engl J Med 349:1006–1007
Markowitz GS, Perazella MA (2009) Acute phosphate nephropathy. Kidney Int 76:1027–1034
Kan WC, Wang HY, Chien CC, Tan CK, Lin CY, Su SB (2012) Intermediate bioelectrolyte changes after phospho-soda or polyethylene glycol precolonoscopic laxatives in a population undergoing health examinations. Nephrol Dial Transplant 27:752–757
Larson RA, Pui CH. Tumor lysis syndrome: Prevention and treatment. Uptodate 2012. http://www.uptodate.com/contents/tumor-lysis-syndrome-prevention-and-treatment?source=see_link. Accessed 30 April 2012
López I, Rodríguez-Ortiz ME, Almadén Y, Guerrero F, de Oca AM, Pineda C, Shalhoub V, Rodríguez M, Aguilera-Tejero E (2011) Direct and indirect effects of parathyroid hormone on circulating levels of fibroblast growth factor 23 in vivo. Kidney Int 80:475–482
Saito H, Maeda A, Ohtomo S, Hirata M, Kusano K, Kato S, Ogata E, Segawa H, Miyamoto K, Fukushima N (2005) Circulating FGF-23 is regulated by 1-alpha,25-dihydroxyvitamin D3 and phosphorus in vivo. J Biol Chem 280:2543–2549
Martin A, David V, Quarles LD (2012) Regulation and function of the FGF23/klotho endocrine pathways. Physiol Rev 92:131–155
Silver J, Rodriguez M, Slatopolsky E. (2012) FGF23 and PTH–double agents at the heart of CKD. Nephrol Dial Transplant. Mar 23. (Epub ahead of print)
Nishida Y, Taketani Y, Yamanaka-Okumura H, Imamura F, Taniguchi A, Sato T, Shuto E, Nashiki K, Arai H, Yamamoto H, Takeda E (2006) Acute effect of oral phosphate loading on serum fibroblast growth factor 23 levels in healthy men. Kidney Int 70:2141–2147
Isakova T, Gutierrez O, Shah A, Castaldo L, Holmes J, Lee H, Wolf M (2008) Postpandrial mineral metabolism and secondary hyperparathyroidism in early CKD. J Am Soc Nephrol 19:615–623
Vervloet MG, van Ittersum FJ, Büttler RM, Heijboer AC, Blankenstein MA, ter Wee PM (2011) Effects of phosphate and calcium intake on fibroblast growth factor 23. Clin J Am Soc Nephrol 6:383–389
Ito N, Fukumoto S, Takeuchi Y, Takeda S, Suzuki H, Yamashita T, Fujita T (2007) Effect of acute changes of serum phosphate on fibroblast growth factor (FGF23) levels in humans. J Bone Miner Metab 25:419–422
Rodriguez-Ortiz ME, Lopez I, Muñoz-Castañeda JR, Martinez-Moreno JM, Ramírez AP, Pineda C, Canalejo A, Jaeger P, Aguilera-Tejero E, Rodriguez M, Felsenfeld A, Almaden Y (2012) Calcium deficiency reduces circulating levels of FGF23. J Am Soc Nephrol 23:1190–1197
Ferrari SL, Bonjour JP, Rizzoli R (2005) Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men. J Clin Endocrinol Metab 90:1519–1524
Lien YH (2008) Is bowel preparation before colonoscopy a risky business for the kidney? Nat Clin Pract Nephrol 4:606–614
Acknowledgments
This work has been supported by grants from FIS PS09/00447, ISCIII-RETIC REDinREN/RD06/0016 and RD12/0021, Comunidad de Madrid S2010/BMD-2378, Sociedad Española de Nefrología, Ministerio de Ciencia y Tecnología PI10/00072. Programa Intensificación Actividad Investigadora (ISCIII/Agencia Laín-Entralgo/CM) to AO. SYSKID and Eutox.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Additional information
Mariano Rodriguez and Alberto Ortiz contributed equally to this work.
About this article
Cite this article
Gracia-Iguacel, C., Gonzalez-Parra, E., Rodriguez-Osorio, L. et al. Correction of hypocalcemia allows optimal recruitment of FGF-23-dependent phosphaturic mechanisms in acute hyperphosphatemia post-phosphate enema. J Bone Miner Metab 31, 703–707 (2013). https://doi.org/10.1007/s00774-013-0435-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00774-013-0435-z